RecruitingNot ApplicableNCT05300464

A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection

A Clinical Investigation (multicentric, Single Arm, Prospective, Stratified) to Confirm the Ability of MammoWave (microwave Mammogram) in Breast Lesions Detection


Sponsor

Umbria Bioengineering Technologies

Enrollment

600 participants

Start Date

Jan 7, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This is a multicentric, single arm, prospective, stratified by breast density clinical investigation to confirm the ability of the microwave mammogram 'MammoWave' to detect breast lesions. MammoWave is a innovative medical device, class IIa marked CE, which uses microwaves instead of ionazing radiation (x-ray) for breast lesions. Specifically MammoWave employs a novel technique wich generates images by processing very low power (\<1mW) microwave. The MammoWave exam takes few minutes for breast and is performed with the patient lying in a confortable facing down position. MammoWave is safe to be used at any age, in any condition (pregnancy, specific illness and for unlimited number of times.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study evaluates a new breast scanning device called MammoWave, which uses microwaves (not X-rays or compression) to detect breast lesions. It is being tested alongside standard mammography to see if it can accurately identify breast abnormalities. **You may be eligible if...** - You are a woman aged 18 or older - You have already had a mammogram within the last month - You are willing to follow study guidelines **You may NOT be eligible if...** - You have specific physical or medical conditions identified during screening that prevent participation (as determined by the study team) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEClinical investigation medical device class IIa marked CE

Patients should perform MammoWave exam. A short visit should be performed and during this visit a qualitative differentiation would be performed between patients with high density breast, and patients with low density breast. After the patients are ready for MammoWave exam. The exam will composed of two phases: the acquisition and data processing. During the acquisition that sholud takes about 10 minutes the patients would be lying in a prone position, on a bed which is part of the MammoWave. The upper part of MammoWave has a container cup shape, which contains the breast, which also has the function of separate it from the internal parts of the device. After patient is on the bed and MammoWave would start to perform the acquisition. Once the acquisition is completed, the data will be processed through an imaging algorithm, which is integrated in the device. The final output will be composed by one or more images, plus one or more parameters describing the images.


Locations(3)

IRCCS Policlinico San Martino

Genova, Genova, Italy

Ospedale San Giovanni Battista - USL Umbria 2

Foligno, Perugia, Italy

Hospital Universitario de Toledo

Toledo, Spain, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05300464


Related Trials